Eur J Pediatr Surg 2018; 28(05): 445-454
DOI: 10.1055/s-0037-1604115
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Long-Term Outcomes and Quality of Life in Patients after Soave Pull-Through Operation for Hirschsprung's Disease: An Observational Retrospective Study

Viet Quoc Tran
1   Department of Pediatric Surgery, City Children's Hospital, Ho Chi Minh City, Vietnam
2   Hôpital Universitaire des Enfants Reine Fabiola, Bruxelles, Belgique — Université Libre de Bruxelles (ULB), Brussels, Belgium
,
Tania Mahler
3   Department of Gastroenterology, Hôpital Universitaire des Enfants Reine Fabiola, Bruxelles, Belgique — Université Libre de Bruxelles (ULB), Brussels, Belgium
,
Martine Dassonville
2   Hôpital Universitaire des Enfants Reine Fabiola, Bruxelles, Belgique — Université Libre de Bruxelles (ULB), Brussels, Belgium
,
Dinh Quang Truong
1   Department of Pediatric Surgery, City Children's Hospital, Ho Chi Minh City, Vietnam
,
Annie Robert
4   Faculté de santé publique, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain (UCL), Brussels, Belgium
,
Philippe Goyens
5   Laboratory of Pediatrics, Université Libre de Bruxelles (ULB), Brussels, Belgium
,
Henri Steyaert
2   Hôpital Universitaire des Enfants Reine Fabiola, Bruxelles, Belgique — Université Libre de Bruxelles (ULB), Brussels, Belgium
› Author Affiliations
Further Information

Publication History

07 October 2016

28 May 2017

Publication Date:
24 July 2017 (online)

Abstract

Introduction Patients after pull-through operation for Hirschsprung's disease (HD) are at high risk of defecation disorders. This study aimed at investigating their long-term outcomes and quality of life (QoL) in comparison with controls.

Patients and Methods Patients older than 5 years operated on for HD were interviewed to complete detailed questionnaires on bowel function. Patients without neurologic impairment were enrolled in a QoL survey to compare with controls matched for sex and age and selected randomly from the general population using sampling set in a ratio of four controls to one case of HD.

Results In total, 53 operated patients were enrolled. Mean age of the patients was 16 ± 8 years, with 68% boys. Rectosigmoid aganglionosis was the most seen form of HD in 38 (72%) cases. Open Soave was performed in 40 (75.5%) cases, and minimally invasive surgery Soave (MIS Soave) in 13 (24.5%) cases. At investigation, prevalence of fecal incontinence and constipation were 22.6 and 13.2%, respectively. Regarding QoL survey, 45 patients and 180 controls were enrolled, excluding 8 patients with neurologic impairment. Thirty-seven (82.2%) patients were classified as having a good QoL (score ≥ 9 points); whereas six had a fair QoL (5–8 points) and two had a poor QoL (< 5 points). QoL score in the cases and the controls were 10.2 ± 2.5 and 11.9 ± 0.4 points, respectively. Long aganglionosis form of HD was significantly associated with a low QoL (score < 8 points), adjusted odds ratio = 9, 95% confidence interval [1.3; 64.1] (p < 0.05). In subscales analyses, the prevalence of each dimension including fecal continence, school absenteeism, unhappiness or anxiety, food restriction, and peer rejection was significantly higher in operated patients than in controls (p <0.001).

Conclusion Although the QoL of patients operated on for HD in general was with good outcomes, fecal incontinence and constipation still are problematic issues and challenges in a high percentage of patients. Therefore, a long-term and multidisciplinary follow-up is essentially required for these patients.

 
  • References

  • 1 Langer JC. Hirschsprung disease. Curr Opin Pediatr 2013; 25 (03) 368-374
  • 2 Burkardt DD, Graham Jr JM, Short SS, Frykman PK. Advances in Hirschsprung disease genetics and treatment strategies: an update for the primary care pediatrician. Clin Pediatr (Phila) 2014; 53 (01) 71-81
  • 3 Gosemann JH, Friedmacher F, Ure B, Lacher M. Open versus transanal pull-through for Hirschsprung disease: a systematic review of long-term outcome. Eur J Pediatr Surg 2013; 23 (02) 94-102
  • 4 Teitelbaum DH, Coran AG. Long-term results and quality of life after treatment of Hirschsprung's disease and allied disorders. In: Holschneider AM, Puri P. , eds. Hirschsprung's Disease and Allied Disorders. Berlin: Springer; 2008: 387-396
  • 5 Hartman EE, Oort FJ, Sprangers MA. , et al. Factors affecting quality of life of children and adolescents with anorectal malformations or Hirschsprung disease. J Pediatr Gastroenterol Nutr 2008; 47 (04) 463-471
  • 6 Suita S, Taguchi T, Yanai K, Kamimura T, Nakao M, Ikeda K. Longterm outcomes and quality of life after Z-shaped anastomosis for Hirschsprung's disease. J Am Coll Surg 1998; 187 (06) 577-583
  • 7 Stensrud KJ, Emblem R, Bjørnland K. Late diagnosis of Hirschsprung disease--patient characteristics and results. J Pediatr Surg 2012; 47 (10) 1874-1879
  • 8 Rintala RJ, Pakarinen MP. Long-term outcomes of Hirschsprung's disease. Semin Pediatr Surg 2012; 21 (04) 336-343
  • 9 Romero P, Kroiss M, Chmelnik M, Königs I, Wessel LM, Holland-Cunz S. Outcome of transanal endorectal vs. transabdominal pull-through in patients with Hirschsprung's disease. Langenbecks Arch Surg 2011; 396 (07) 1027-1033
  • 10 Dahal GR, Wang JX, Guo LH. Long-term outcome of children after single-stage transanal endorectal pull-through for Hirschsprung's disease. World J Pediatr 2011; 7 (01) 65-69
  • 11 Kim AC, Langer JC, Pastor AC. , et al. Endorectal pull-through for Hirschsprung's disease-a multicenter, long-term comparison of results: transanal vs transabdominal approach. J Pediatr Surg 2010; 45 (06) 1213-1220
  • 12 Bai Y, Chen H, Hao J, Huang Y, Wang W. Long-term outcome and quality of life after the Swenson procedure for Hirschsprung's disease. J Pediatr Surg 2002; 37 (04) 639-642
  • 13 Neuvonen MI, Kyrklund K, Rintala RJ, Pakarinen MP. Bowel function and quality of life after transanal endorectal pull-through for Hirschsprung disease: controlled outcomes up to adulthood. Ann Surg 2017; 265 (03) 622-629
  • 14 Clermidi P, Podevin G, Crétolle C, Sarnacki S, Hardouin JB. The challenge of measuring quality of life in children with Hirschsprung's disease or anorectal malformation. J Pediatr Surg 2013; 48 (10) 2118-2127
  • 15 Fernández Ibieta M, Sánchez Morote JM, Martínez Castaño I. , et al. Quality of life and long term results in Hirschsprung's disease [in Spanish]. Cir Pediatr 2014; 27 (03) 117-124
  • 16 Mills JL, Konkin DE, Milner R, Penner JG, Langer M, Webber EM. Long-term bowel function and quality of life in children with Hirschsprung's disease. J Pediatr Surg 2008; 43 (05) 899-905
  • 17 Moore SW, Millar AJ, Cywes S. Long-term clinical, manometric, and histological evaluation of obstructive symptoms in the postoperative Hirschsprung's patient. J Pediatr Surg 1994; 29 (01) 106-111
  • 18 Kyrklund K, Koivusalo A, Rintala RJ, Pakarinen MP. Evaluation of bowel function and fecal continence in 594 Finnish individuals aged 4 to 26 years. Dis Colon Rectum 2012; 55 (06) 671-676
  • 19 Zakaria OM, El Labban GM, Shams ME. Fecal incontinence after single-stage Soave's pull-through: abdominal versus transanal endorectal pull-through. Ann Pediatr Surg 2012; 8: 5-8
  • 20 Rajindrajith S, Devanarayana NM, Benninga MA. Review article: faecal incontinence in children: epidemiology, pathophysiology, clinical evaluation and management. Aliment Pharmacol Ther 2013; 37 (01) 37-48
  • 21 Tabbers MM, DiLorenzo C, Berger MY. , et al; European Society for Pediatric Gastroenterology, Hepatology, and Nutrition; North American Society for Pediatric Gastroenterology. Evaluation and treatment of functional constipation in infants and children: evidence-based recommendations from ESPGHAN and NASPGHAN. J Pediatr Gastroenterol Nutr 2014; 58 (02) 258-274
  • 22 Han-Geurts IJ, Hendrix VC, de Blaauw I, Wijnen MH, van Heurn EL. Outcome after anal intrasphincteric Botox injection in children with surgically treated Hirschsprung disease. J Pediatr Gastroenterol Nutr 2014; 59 (05) 604-607
  • 23 Brouwer R, Duthie G. Sacral nerve neuromodulation is effective treatment for fecal incontinence in the presence of a sphincter defect, pudendal neuropathy, or previous sphincter repair. Dis Colon Rectum 2010; 53 (03) 273-278
  • 24 Tjandra JJ, Chan MK, Yeh CH, Murray-Green C. Sacral nerve stimulation is more effective than optimal medical therapy for severe fecal incontinence: a randomized, controlled study. Dis Colon Rectum 2008; 51 (05) 494-502
  • 25 Levitt M, Peña A. Update on pediatric faecal incontinence. Eur J Pediatr Surg 2009; 19 (01) 1-9
  • 26 Gunnarsdóttir A, Larsson LT, Arnbjörnsson E. Transanal endorectal vs. Duhamel pull-through for Hirschsprung's disease. Eur J Pediatr Surg 2010; 20 (04) 242-246
  • 27 Hadidi A. Transanal endorectal pull-through for Hirschsprung's disease: a comparison with the open technique. Eur J Pediatr Surg 2003; 13 (03) 176-180
  • 28 Catto-Smith AG, Trajanovska M, Taylor RG. Long-term continence in patients with Hirschsprung's disease and Down syndrome. J Gastroenterol Hepatol 2006; 21 (04) 748-753
  • 29 Powers MK, Brown ET, Hogan RM, Martin AD, Ortenberg J, Roth CC. Trends in toilet training and voiding habits among children with Down syndrome. J Urol 2015; 194 (03) 783-787
  • 30 Levitt MA, Martin CA, Olesevich M, Bauer CL, Jackson LE, Peña A. Hirschsprung disease and fecal incontinence: diagnostic and management strategies. J Pediatr Surg 2009; 44 (01) 271-277
  • 31 Menezes M, Corbally M, Puri P. Long-term results of bowel function after treatment for Hirschsprung's disease: a 29-year review. Pediatr Surg Int 2006; 22 (12) 987-990
  • 32 Meinds RJ, Eggink MC, Heineman E, Broens PM. Dyssynergic defecation may play an important role in postoperative Hirschsprung's disease patients with severe persistent constipation: analysis of a case series. J Pediatr Surg 2014; 49 (10) 1488-1492
  • 33 Diseth TH, Bjørnland K, Nøvik TS, Emblem R. Bowel function, mental health, and psychosocial function in adolescents with Hirschsprung's disease. Arch Dis Child 1997; 76 (02) 100-106